AffiliationUniv Arizona, Coll Med Phoenix, Dept Med, Div Clin Data Analyt & Decis Support
MetadataShow full item record
PublisherELSEVIER SCIENCE LONDON
CitationWoosley RL, Black K, Heise CW, Romero K (2018) CredibleMeds.org: what does it offer? Trends Cardiovasc Med 28(2):94–99
Rights© 2017 Elsevier Inc. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractSince the 1990s, when numerous non-cardiac drugs were first recognized to have the potential to prolong the QT interval and cause torsades de pointes (TdP), clinicians, drug regulators, drug developers, and clinical investigators have become aware of the complexities of assessing evidence and determining TdP causality for the many drugs being marketed or under development. To facilitate better understanding, the Arizona Center for Education and Research on Therapeutics, known as AZCERT, has developed the CredibleMeds.org website which includes QTdrugs, a listing of over 220 drugs placed in four risk categories based on their association with QT prolongation and TdP. Since the site was launched in 1999, it has become the single and most reliable source of information of its kind for patients, healthcare providers, and research scientists. Over 96,000 registered users rely on the QTdrugs database as their primary resource to inform their medication use, their prescribing or their clinical research into the impact of QT-prolonging drugs and drug induced arrhythmias. The QTdrugs lists are increasingly used as the basis for clinical decision support systems in healthcare and for metrics of prescribing quality by healthcare insurers. A free smartphone app and an application program interface enable rapid and mobile access to the lists. Also, the CredibleMeds website offers numerous educational resources for patients, educators and healthcare providers that foster the safe use of medications.
Note12 month embargo; published online: 01 August 2017
VersionFinal accepted manuscript
- Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death.
- Authors: Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S
- Issue date: 2017 Jun
- Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.
- Authors: Grouthier V, Lebrun-Vignes B, Glazer AM, Touraine P, Funck-Brentano C, Pariente A, Courtillot C, Bachelot A, Roden DM, Moslehi JJ, Salem JE
- Issue date: 2018 Nov
- [Drug induced QT prolongation].
- Authors: Altmann D, Eggmann U, Ammann P
- Issue date: 2008
- Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
- Authors: Das B, Rawat VS, Ramasubbu SK, Kumar B
- Issue date: 2019 Dec
- Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
- Authors: Khan Q, Ismail M, Khan S
- Issue date: 2017 Dec 1